Modulation of the impaired drug metabolism in Sarcoma-180 bearing mice by echitamine chloride

Cancer Biochemistry Biophysics

Volumn 17, Issue 1-2, 1999, Pages 79-88

  Saraswathi, Viswanathan ^a   Mathuram, Venkatanarasimhan ^b   Subramanian, Sorimuthu ^a   Govindasamy, Saminathan ^a  

^a UNIVERSITY OF MADRAS   (India)

^b Captain Srinivasa Murthy Drug R ^*  (India)

Author keywords

Anticancer; Cyt b5; Cyt P450; Echitamine chloride; Microsomes; Sarcoma 180

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT; APOPROTEIN; CYTOCHROME B5; CYTOCHROME P450; ECHITAMINE; GLUCOSE 6 PHOSPHATASE; HEMOPROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; TUMOR PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANCER TRANSPLANTATION; DRUG DETOXIFICATION; DRUG EFFECT; DRUG SCREENING; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; LIVER MICROSOME; METABOLISM; MOUSE; SARCOMA 180;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPROTEINS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES B5; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INDUCTION; GLUCOSE-6-PHOSPHATASE; HEMEPROTEINS; METABOLIC DETOXICATION, DRUG; MICE; MICROSOMES, LIVER; NADH DEHYDROGENASE; NADPH-FERRIHEMOPROTEIN REDUCTASE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; SARCOMA 180;

EID: 0032847049     PISSN: 03057232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Banerjee S., K. Prashar, A, Kumar and A.R. Rao (1996). Modulatory influence of alcoholic extract of Ocimum leaves on carcinogen- metabolizing enzyme activities and reduced glutathione levels in mouse. Nutr. Cancer. 25: 205-217
2. Beck W T., Dedmon M.L., and M.N. Owllette (1982). Biochemical basis for impaired drug metabolism in tumor-bearing rats. Evidence for altered regulation of hepatic microsomal hemeprotein synthesis. Biochem. Pharmacol. 31: 1535-1543.
3. Boulds B.M., M. Mac Daugall, D.W. Shoeman and D.L. Azarnoff (1972). Evidence that inhibition of hepatic drug oxidation by tumors is mediated by a circulating humor. Proc. Soc. Exp. Biol. Med. 139: 1353-1355.
4. Brown H.D., S.K. Chattopadhyay, S.N. Pennington, J.S. Spratt and H.P. Moris (1971). Mixed function oxidation in Tumors. Br. J. Cancer. 25: 135-144.
5. Franchi G. and R. Rosso (1969). Metabolic rate of zoxazolamine in tumor bearing rats. Biochem. Pharmacol. 18: 236-238.
6. Gielen E., K. Jacques, Goujon Francine and D.W. Nebert (1972). Genetic regulation of arylhydrocarbon hydroxylase induction II. Simple mendelian expression in mouse tissues in vivo. J. Biol. Chem., 247: 1125-1137.
7. Haugen D.A., M.J. Coon and D.W. Neben (1976). Induction of multiple forms of mouse liver cytochrome P-450. Evidence for genetically controlled de novo protein synthesis in response to treatment with (-naphthoflavone or pentobarbital. J. Biol. Chem., 251: 1817-1827.
8. Kamarajan P., N. Sekar, V. Mathuram and S. Govindasamy. (1991). Antitumor effect of Echitamine chloride on methylcholanthrene induced fibrosarcoma in rats. Biochem. Int. 25: 491-498.
9. Kennedy K.A., S. Prockwell, and A.C. Sartorelli (1980). Preferential activation of Mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res. 40: 2356-2360.
10. Kerremans A.L. (1996). Cytochrome P450 isoenzymes: importance for the internist. Neth. J. Med. 48: 237-243.
11. Kivisto K T., H.K. Kroemer, and M. Eichelbaum (1995). The role of human cytochrome P450 enzymes in the metabolism of anticancer agents; implications for drug interactions. Br. J. Clin. Pharmacol. 40: 523-530.
12. Koide H., and R. Oda (1959). Pathological occurrence of glucose-6 phosphatase in serum in liver diseases. Clin. Chim. Acta 4: 549-553.
13. Lowry O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall (1951). Protein measurement with the folin-phenol reagent. J. Biol. Chem. 193. 265-275.
14. Mohana K., and K.K. Purushothaman (1983). Anticancer activity of echitamine chloride. J. Res. Ayur. Siddha. 4: 111-114
15. Omura T. and R Sato (1964).The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239: 2370-2378.
16. Omura T. and R. Sato (1964). The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem. 239: 2379-2385.
17. Phillips A.H and R.G. Langdon (1962) Hepatic triphosphopyridine nucleotide - cytochrome C reductase: Isolation, characterization and kinetic studies. J. Biol. Chem. 237: 2652-2660.
18. Rosso R., M.G. Daneoli and G. Franchi (1971) Garattini S. Impairment of drug metabolism in tumor-bearing animals. Eur. J. Cancer. 7: 565-577.
19. Sardar S., M. Chatterjee, S. Ghosh and K. Roy (1996). Role of vitamin D3 on the activity patterns of hepatic drug metabolizing enzymes in transplantable murine lymphoma. Cancer invest. 14: 328-334.
20. Sarkar A., B. Mukherjee, M. Rana and M. Chatterjee (1994). Comparative patterns of hepatic drug metabolizing enzymes and their possible correlation with chromosomal aberrations in transplantable murine lymphoma; a time course study. Cancer Invest. 12: 477-483.
21. Strittmatter P. and S.F. Velick (1956). A microsomal cytochrome reductase specific for diphosphopyridine nucleotide. J. Biol. Chem 221: 277-286.
22. Takahashi A. and R. Kato (1969). Effect of Toxohormone on microsomal cytochromes and hydroxylating systems of rat liver. J. Biochem. (Tokyo) 65: 325-327.
23. Young R.W. and H.W. Fulhorst (1965). Recovery of S35 radioactivity from protein-bearing polyacrylamide gel. Analyt. Biochem. 11: 389-391.